Yet another potential ‘cure’ from gene technology as a small trial with haemophilia A sufferers has shown that injecting high doses of the faulty gene restores the clotting ability of their blood to near normal (www.bbc.co.uk/news/health-42337396). Prior to this, people (generally males) had to inject themselves with clotting factor on alternate days and could still develop painful bleeding in their joints as well as life threatening complications to wounds, tooth extraction et cetera. It is not yet certain how long the effects of the treatment lasts (it could be life-long) but it clearly improves quality of life.
No comments:
Post a Comment